
Xylocare Limited
About Xylocare Limited
Data last updated:
Xylocare Limited is a public limited company based in Bhopal, Madhya Pradesh, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 18 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2011PLC025627. Its GSTIN is 23AAACX0990R1ZT (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors including Amit Kapoor and Ritu Kapoor.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6 – 7 Iiird Floor Metro Plaza Bittan Market Arera Colony, Bhopal, Madhya Pradesh, India – 452016.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.62 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹4.32 Lakh (net margin -23.2%) and EBITDA of -₹4.31 Lakh (EBITDA margin -23.2%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 1% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Xylocare Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address6 – 7 Iiird Floor Metro Plaza Bittan Market Arera Colony, Bhopal, Madhya Pradesh, India – 452016
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Xylocare Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Xylocare is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Xylocare Limited, buy the company report.
Financials of Xylocare Limited
FY 2025 filings availableXylocare Limited reported revenue of ₹18.62 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 8% growth in the latest year. EBITDA fell 130% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.31 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.32 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -23.2% | ||||
| Net Profit Margin | -23.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xylocare Limited, buy the company report.
Board of directors of Xylocare Limited
Xylocare has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Kapoor | Director | 18 Mar 2011 | 15 Years 8 Months | Current |
| Rajesh Goyal | Additional Director | 18 Apr 2025 | 1 Years 7 Months | Current |
| Ritu Kapoor Also directs: Premanchal Overseas Private Limited | Director | 18 Mar 2011 | 15 Years 8 Months | Current |
Peer comparison
Xylocare Limited is compared with the 4 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Greenfission Chemicals Private Limited | ₹18.8 Lakh (FY 2023) | 228.0% | Chennai, Tamil Nadu, India | |||
| Marvel Global Limited | ₹18.72 Lakh (FY 2022) | -94.0% | Delhi, India | |||
| Xylocare Limitedthis company | ₹18.62 Lakh (FY 2025) | -₹4.32 Lakh | -23.2% | 8.0% | Bhopal, Madhya Pradesh, India | |
| Welkin Enzyme and Chemical Private Limited | ₹18.39 Lakh (FY 2025) | -2.0% | Delhi, India | |||
| Bharani Petrochemicals Private Limited | ₹18.37 Lakh (FY 2025) | 30.0% | Virudhunagar, Tamil Nadu, India |
To see the full peer comparison of Xylocare Limited, buy the company report.
Auditor
Xylocare Limited is audited by BHAWSAR & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHAWSAR & CO | FY 2021 | 004502C |
Shareholding
The shareholding of Xylocare Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Xylocare Limited, buy the company report.
Legal cases
No court or tribunal cases involving Xylocare Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xylocare Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xylocare has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACX0990R1ZT | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Xylocare Limited, buy the company report.
Recent activity
Xylocare Limited has 9 board changes on record since 2011: 4 appointments and 5 cessations. The latest: Jeene Singh ceased to be Director on 24 Apr 2025.
Frequently asked questions
Xylocare is an active public limited company based in Bhopal, Madhya Pradesh, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 18 March 2011 (15+ years old) and is registered under CIN U24230MP2011PLC025627.
Xylocare has 3 current directors:
- Amit Kapoor - Director
- Rajesh Goyal - Additional Director
- Ritu Kapoor - Director
The latest financial statements of Xylocare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Xylocare is 23AAACX0990R1ZT, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Xylocare is U24230MP2011PLC025627. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xylocare was incorporated on 18 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Xylocare by revenue are Greenfission Chemicals Private Limited, Marvel Global Limited, Welkin Enzyme and Chemical Private Limited, Bharani Petrochemicals Private Limited, all in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jeene Singh ceased to be Director on 24 Apr 2025. Rajesh Goyal was appointed as Additional Director on 18 Apr 2025. Abhijeet Deshmukh ceased to be Managing Director on 04 Sep 2019. Xylocare has 9 board changes on record in total.
The registered office of Xylocare is at 6 – 7 Iiird Floor Metro Plaza Bittan Market Arera Colony, Bhopal, Madhya Pradesh, India – 452016.
Xylocare operates in the chemicals and materials industry, in the industrial chemicals segment.
The compliance status of Xylocare is active non-compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.

